|
|
|
| Expression of CircRNA_0006633 in Liver Cancer Tissues and Its Effect on Cell Proliferation |
| LUO Ze-bin, CHEN Zhi-an,CHEN Long-lin,et al |
| Department of General Surgery, Dafeng Hospital, Shantou, Guangdong 515154 |
|
|
|
|
Abstract 【Objective】To detect the expression of circRNA_0006633 in liver cancer tissues and explore its biological regulation on cell proliferation, apoptosis and cell cycle.【Methods】Real-time quantitative polymerase chain reaction (RT-qPCR) was used to analyzed the expression level of circRNA_0006633 in liver cancer tissues and adjacent normal tissues, while the relationship between circRNA_0006633's expression and clinicopathological parameters was further determined. Then biological effects of circRNA_0006633 overexpression by lentivirus-mediated-plasmids (circ_0006633-pcDNA 3.1 plasmids)on cell proliferation, apoptosis, and cycle were investigated by RT-qPCR, western blot, CCK8 and flow cytometry.【Results】Compared to the paired adjacent normal tissues, the expression level of circRNA_0006633 in liver cancer tissues was lower. Furthermore, the low expression circRNA_0006633 was negatively correlated with survival outcome. Upregulation of circRNA_0006633 effectively reduced cell proliferation, increased apoptosis and arrested cells at G2/M phages, while the epithelial-mesenchymal transition (EMT)-related proteins were regulated as well.【Conclusion】Expression of circRNA_0006633 is lower in liver cancer tissues. circRNA_0006633 can inhibit the process of epithelial-mesenchymal transition pathway activation and reduce the proliferation of liver cancer cells, which provides new ideas for the treatment of liver cancer.
|
|
Received: 11 March 2019
|
|
|
|
|
|
[1] Fu C,Wang L,Tian G,et al. Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133(+) HepG2 liver cancer cells[J].Oncol Lett,2019,17(2):1798-1806.
[2] Bi W, Huang J, Nie C, et al. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of beta-catenin pathway[J].J Exp Clin Cancer Res,2018,37(1):275.
[3] Lu R, Shao Y, Ye G, et al. Low expression of hsa_circ_0006633 in human gastric cancer and its clinical significances[J].Tumour Biol,2017,39(6):1393385489.
[4] Li X, Huang L, Leng X. Analysis of prognostic factors of more/equal to10 years of survival for liver cancer patients after liver transplantation[J].J Cancer Res Clin Oncol,2018,144(12):2465-2474.
[5] Shimada H, Yajima S, Oshima Y, et al.Liquid Biopsy in Multimodal Treatment of Esophageal Carcinoma[J].Gan To Kagaku Ryoho,2015,42(11):1335-1337.
[6] Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency[J].Nature,2013,495(7441):333-338.
[7] Zhang HD, Jiang LH, Sun DW, et al. CircRNA: a novel type of biomarker for cancer[J].Breast Cancer,2018,25(1):1-7.
[8] Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges[J].Nature,2013,495(7441):384-388.
[9] Huang G, Zhu H, Shi Y, et al. cir-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/beta-catenin pathway[J].PLoS One,2015,10(6):e131225.
[10] Bachmayr-Heyda A, Reiner A T, Auer K, et al. Correlation of circular RNA abundance with proliferation--exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues[J].Sci Rep,2015,5:8057.
[11] Ghosal S, Das S, Sen R, et al. Circ2Traits: a comprehensive database for circular RNA potentially associated with disease and traits[J].Front Genet,2013,4:283. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(7): 1414-1415. |
|
|
|
|
2020, Vol. 37 
